Nature
Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature publishes landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events that enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community.
-
Stories of people, past, present and future: Books in brief
Nature, Published online: 21 February 2025; doi:10.1038/d41586-025-00555-9
Andrew Robinson reviews five of the best science picks. -
Tropical forest’s last old growth is being toppled — illegally
Nature, Published online: 21 February 2025; doi:10.1038/d41586-025-00506-4
Satellite imagery helps to identify two hotspots of deforestation in the Atlantic Forest along Brazil’s eastern coast. -
Cancer evolution could inform targets for personalized anticancer vaccines
Nature, Published online: 21 February 2025; doi:10.1038/d41586-025-00467-8
Through comprehensive genomic and immune analyses, mechanisms of lung cancer resistance after treatment with EGFR inhibition and vaccine therapy were investigated. This case report, together with data from the longitudinal lung cancer study TRACERx, highlight the importance of understanding when targeted variants are acquired during the cancer’s evolutionary history. -
How AI is revealing the language of the birds
Nature, Published online: 21 February 2025; doi:10.1038/d41586-025-00539-9
Crows make a huge number of different sounds; Artificial Intelligence could help us understand what they mean. -
Putting early cancer detection to the test
Nature, Published online: 21 February 2025; doi:10.1038/d41586-025-00530-4
Identifying tumours using blood samples is possible, but researchers are still working out how to validate and deploy multi-cancer tests.